Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.
暂无分享,去创建一个
[1] K. Ellenbogen,et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. , 1997, Journal of the American College of Cardiology.
[2] M. Scheinman. Atrial fibrillation and congestive heart failure: the intersection of two common diseases. , 1998, Circulation.
[3] W G Stevenson,et al. Prognostic Significance of Atrial Fibrillation in Advanced Heart Failure: A Study of 390 Patients , 1991, Circulation.
[4] D. Levy,et al. The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.
[5] G. Kay,et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.
[6] S. Nattel,et al. Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure , 2001, Circulation.
[7] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[8] S. Yusuf,et al. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. , 2000, Chest.
[9] S. Nattel. Ionic determinants of atrial fibrillation and Ca2+ channel abnormalities : cause, consequence, or innocent bystander? , 1999, Circulation research.
[10] P C Deedwania,et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. , 1998, Circulation.
[11] H. Kay,et al. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. , 1987, The American journal of cardiology.
[12] D. Levy,et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.
[13] S. Hohnloser,et al. Atrial Fibrillation and Congestive Heart Failure: Specific Considerations at the Intersection of Two Common and Important Cardiac Disease Sets , 2002, Journal of cardiovascular electrophysiology.
[14] W. Gaasch. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. , 1994, JAMA.
[15] H. Crijns,et al. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. , 1998, The American journal of cardiology.
[16] M A Waclawiw,et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.
[17] D E Grobbee,et al. The epidemiology of heart failure. , 1997, European heart journal.
[18] H. Doval,et al. Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.
[19] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.
[20] D. Brutsaert,et al. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. , 2002, Circulation.
[21] R. Fagard,et al. Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients , 1997, Heart.
[22] L. Stevenson,et al. Medical management of advanced heart failure. , 2002, JAMA.
[23] D. Brutsaert,et al. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. , 2002, Circulation.
[24] S. Vaziri,et al. Echocardiographic Predictors of Nonrheumatic Atrial Fibrillation: The Framingham Heart Study , 1994, Circulation.
[25] P. Brugada,et al. Tachycardiomyopathy: Mechanisms and Clinical Implications , 1996, Pacing and clinical electrophysiology : PACE.
[26] S. Kimmel,et al. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. , 1999, The American journal of cardiology.
[27] L. Køber,et al. Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy , 2001, Circulation.
[28] F. Solti,et al. The effect of atrial dilatation on the genesis of atrial arrhythmias. , 1989, Cardiovascular research.
[29] S. Nattel,et al. Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs , 2002, Circulation.
[30] E. Michelson,et al. The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. , 1983, American heart journal.
[31] S Nattel,et al. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. , 2000, Circulation.
[32] A. Camm,et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.
[33] G. Tomaselli,et al. Electrophysiological remodeling in hypertrophy and heart failure. , 1999, Cardiovascular research.
[34] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[35] S. Yusuf,et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.
[36] A L Waldo,et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.
[37] S. Nattel,et al. Ionic Remodeling in the Heart: Pathophysiological Significance and New Therapeutic Opportunities for Atrial Fibrillation , 2000, Circulation research.
[38] W. Stevenson,et al. Atrial fibrillation in heart failure. , 1999, The New England journal of medicine.
[39] W. Aronow,et al. Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm. , 2001, The American journal of cardiology.
[40] S. Hohnloser,et al. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial , 2000, The Lancet.
[41] I. V. Van Gelder,et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. , 2000, European heart journal.
[42] M. Kienzle,et al. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. , 1988, The American journal of medicine.
[43] S Nattel,et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.
[44] D. Moser,et al. Improving outcomes in heart failure: It's not unusual beyond usual care. , 2002, Circulation.
[45] H. Crijns,et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. , 1993, The American journal of cardiology.
[46] I. V. Van Gelder,et al. Heart failure and atrial fibrillation: current concepts and controversies. , 1997, Heart.
[47] Hemodynamic Consequences of Cardiac Arrhythmias , 1988 .
[48] A. Keogh,et al. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. , 1990, The American journal of cardiology.
[49] C. Solares,et al. Tachycardia-induced cardiomyopathy. , 2003, The American journal of medicine.